Climb Bio, Inc.

CLYM • XNAS • Stock Fundamentals

Climb Bio, Inc. is a pharmaceutical preparations company trading on XNAS, led by CEO Aoife Brennan BCh MMSc, with a market cap of $624.7M.

Market Cap$624.7M

Employees11.0

CEOAoife Brennan BCh MMSc

CountryUnited States of America

PHARMACEUTICAL PREPARATIONS

Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026

Next EarningsAug 11, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Climb Bio, Inc.

Climb Bio, Inc. (CLYM) has a market capitalization of $624.7M and trades on XNAS.

Climb Bio, Inc. has approximately 11 employees.